| Product NDC: | 68669-145 |
| Proprietary Name: | IQUIX |
| Non Proprietary Name: | levofloxacin |
| Active Ingredient(s): | 15 mg/mL & nbsp; levofloxacin |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68669-145 |
| Labeler Name: | Vistakon Pharmaceuticals LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021571 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20040601 |
| Package NDC: | 68669-145-99 |
| Package Description: | 1 mL in 1 BOTTLE (68669-145-99) |
| NDC Code | 68669-145-99 |
| Proprietary Name | IQUIX |
| Package Description | 1 mL in 1 BOTTLE (68669-145-99) |
| Product NDC | 68669-145 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | levofloxacin |
| Dosage Form Name | SOLUTION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20040601 |
| Marketing Category Name | NDA |
| Labeler Name | Vistakon Pharmaceuticals LLC |
| Substance Name | LEVOFLOXACIN |
| Strength Number | 15 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |